Authors: Rajan P. Kulkarni
Published: 2019-06-19
DOI: 10.1126/scitranslmed.aax9566
Source: Full article
Mouse models of pancreatic ductal adenocarcinoma respond to immunotherapy when given in combination with the cyclooxygenase-2 inhibitor celecoxib.